302 related articles for article (PubMed ID: 19945236)
1. Treatment options for threatened miscarriage.
Qureshi NS
Maturitas; 2009 Dec; 65 Suppl 1():S35-41. PubMed ID: 19945236
[TBL] [Abstract][Full Text] [Related]
2. Dydrogesterone in threatened miscarriage: a Malaysian experience.
Pandian RU
Maturitas; 2009 Dec; 65 Suppl 1():S47-50. PubMed ID: 20005647
[TBL] [Abstract][Full Text] [Related]
3. Dydrogesterone support in threatened miscarriage.
El-Zibdeh MY; Yousef LT
Maturitas; 2009 Dec; 65 Suppl 1():S43-6. PubMed ID: 20007011
[TBL] [Abstract][Full Text] [Related]
4. Luteal support: progestogens for pregnancy protection.
Daya S
Maturitas; 2009 Dec; 65 Suppl 1():S29-34. PubMed ID: 19913373
[TBL] [Abstract][Full Text] [Related]
5. The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage.
Siew JYS; Allen JC; Hui CYY; Ku CW; Malhotra R; Østbye T; Tan TC
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():319-324. PubMed ID: 30077119
[TBL] [Abstract][Full Text] [Related]
6. Dydrogesterone use in early pregnancy.
Mirza FG; Patki A; Pexman-Fieth C
Gynecol Endocrinol; 2016; 32(2):97-106. PubMed ID: 26800266
[TBL] [Abstract][Full Text] [Related]
7. First trimester threatened miscarriage treatment with human chorionic gonadotrophins: a randomised controlled trial.
Qureshi NS; Edi-Osagie EC; Ogbo V; Ray S; Hopkins RE
BJOG; 2005 Nov; 112(11):1536-41. PubMed ID: 16225575
[TBL] [Abstract][Full Text] [Related]
8. Oral dydrogesterone for prevention of miscarriage in threatened miscarriage: a randomized, double-blind, placebo-controlled trial.
Kuptarak A; Phupong V
J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2333929. PubMed ID: 38570191
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of dydrogesterone for the treatment of threatened miscarriage.
Carp H
Gynecol Endocrinol; 2012 Dec; 28(12):983-90. PubMed ID: 22794306
[TBL] [Abstract][Full Text] [Related]
10. Double-blind controlled trial of progesterone substitution in threatened abortion.
Gerhard I; Gwinner B; Eggert-Kruse W; Runnebaum B
Biol Res Pregnancy Perinatol; 1987; 8(1 1ST Half):26-34. PubMed ID: 2437967
[TBL] [Abstract][Full Text] [Related]
11. Human chorionic gonadotropin, estradiol, progesterone, prolactin, and B-scan ultrasound monitoring of complications in early pregnancy.
Yuen BH; Livingston JE; Poland BJ; Wittmann BK; Sy L; Cannon W
Obstet Gynecol; 1981 Feb; 57(2):207-14. PubMed ID: 7465126
[TBL] [Abstract][Full Text] [Related]
12. Human chorionic gonadotrophin for threatened miscarriage.
Devaseelan P; Fogarty PP; Regan L
Cochrane Database Syst Rev; 2010 May; (5):CD007422. PubMed ID: 20464754
[TBL] [Abstract][Full Text] [Related]
13. Use of oral progestogen in women with threatened miscarriage in the first trimester: a randomized double-blind controlled trial.
Chan DMK; Cheung KW; Ko JKY; Yung SSF; Lai SF; Lam MT; Ng DYT; Lee VCY; Li RHW; Ng EHY
Hum Reprod; 2021 Feb; 36(3):587-595. PubMed ID: 33331637
[TBL] [Abstract][Full Text] [Related]
14. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study.
Ghosh S; Chattopadhyay R; Goswami S; Chaudhury K; Chakravarty B; Ganesh A
J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464
[TBL] [Abstract][Full Text] [Related]
15. Effect of progestogen for women with threatened miscarriage: a systematic review and meta-analysis.
Li L; Zhang Y; Tan H; Bai Y; Fang F; Faramand A; Chong W; Hai Y
BJOG; 2020 Aug; 127(9):1055-1063. PubMed ID: 32324957
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for spontaneous abortion in early symptomatic first-trimester pregnancies.
Gracia CR; Sammel MD; Chittams J; Hummel AC; Shaunik A; Barnhart KT
Obstet Gynecol; 2005 Nov; 106(5 Pt 1):993-9. PubMed ID: 16260517
[TBL] [Abstract][Full Text] [Related]
17. [Current role of progesterone therapy in the prevention of spontaneous abortion and in the treatment of threatened abortion].
Marzetti L; Boni T; Fazzio M; Giobbe M
Minerva Ginecol; 2000 Dec; 52(12):515-9. PubMed ID: 11310149
[TBL] [Abstract][Full Text] [Related]
18. [The value of determinations of human chorionic gonatrophin, human placental lactogen, progesterone and oestriol in women with threatened abortion (author's transl)].
Gerhard I; Runnebaum B
Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):785-99. PubMed ID: 700341
[TBL] [Abstract][Full Text] [Related]
19. Dydrogesterone in the reduction of recurrent spontaneous abortion.
El-Zibdeh MY
J Steroid Biochem Mol Biol; 2005 Dec; 97(5):431-4. PubMed ID: 16253504
[TBL] [Abstract][Full Text] [Related]
20. Dydrogesterone in threatened abortion: pregnancy outcome.
Omar MH; Mashita MK; Lim PS; Jamil MA
J Steroid Biochem Mol Biol; 2005 Dec; 97(5):421-5. PubMed ID: 16293412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
